Publications


A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.
Int J Clin Oncol 2017 Apr 20. Epub 2017 Apr 20.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.






Dose calculation accuracies in whole breast radiotherapy treatment planning: a multi-institutional study.
Radiol Phys Technol 2015 Jul 3;8(2):200-8. Epub 2015 Feb 3.
Department of Radiation Oncology, Saitama Medical University Saitama Medical Center, 1981, Kamoda, Kawagoe City, Saitama, 350-8550, Japan,



Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
J Thorac Oncol 2014 Sep;9(9):1370-6
*Radiation Oncology Center, Ofuna Chuo Hospital, Kanagawa, Japan; †Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan; ‡Department of Radiology, Tokai University School of Medicine, Kanagawa, Japan; and §Department of Radiology, Keio University School of Medicine, Tokyo, Japan.



Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer.
J Radiat Res 2014 May 17;55(3):494-501. Epub 2013 Oct 17.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.








A consensus-based guideline defining clinical target volume for primary disease in external beam radiotherapy for intact uterine cervical cancer.
Jpn J Clin Oncol 2011 Sep;41(9):1119-26
Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan.


A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.
Jpn J Clin Oncol 2010 May 4;40(5):456-63. Epub 2010 Feb 4.
Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, Nishihara-cho, Okinawa 903-0215, Japan.




A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).
Jpn J Clin Oncol 2009 Oct 23;39(10):638-43. Epub 2009 Jun 23.
Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202.
Radiat Oncol 2009 Jun 2;4:16. Epub 2009 Jun 2.
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).
Jpn J Clin Oncol 2008 May 3;38(5):387-9. Epub 2008 Apr 3.
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.
Int J Radiat Oncol Biol Phys 2007 Jun 23;68(2):416-25. Epub 2007 Mar 23.
Department of Radiation Oncology and Image-applied Therapy, Kyoto University, Kyoto, Japan.



Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
Cancer Sci 2006 Feb;97(2):163-6
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1, Shikata-cho, Okayama 700-8558, Japan.





OF